文献速递消化内镜

清醒镇静内镜耐受性患者报告量表的开发与验证

Development and validation of a patient-reported scale for tolerability of endoscopic procedures using conscious sedation.
PubMed 文献 · Gastrointest Endosc · 2020-12-30

本研究开发并验证了用于评估清醒镇静内镜耐受性的患者报告体验量表PRO-STEP,包含术中不适/疼痛与知晓度2个问题及术后疼痛、恶心、腹胀等4个问题,采用0-10分Likert评分。

要点

  • PRO-STEP量表涵盖术中不适/疼痛与知晓度及术后疼痛、恶心、腹胀等维度
  • 结肠镜是回忆中耐受性最差的操作,术中知晓评分均值5.1
  • 咪达唑仑用量增加与结肠镜术中知晓评分≥7风险降低相关

核心结论

  • PRO-STEP是一种简便的患者报告体验量表,可在多种清醒镇静内镜操作后使用。

主要发现

  • 结肠镜回忆耐受性最差,术中知晓评分均值5.1±3.8,不适评分均值2.6±2.7。

关键数值与推荐

  • PRO-STEP含2个维度:术中2问(不适/疼痛、知晓),术后4问(疼痛、恶心、腹胀、咽喉或肛门疼痛),均0-10分Likert评分。

临床怎么用

  • 可在门诊患者离开内镜中心时施用PRO-STEP,评估清醒镇静内镜耐受性。
  • 未来需关注其在不良事件预测中的表现。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Patient-reported experience measures (PREMs) assessing the tolerability of endoscopic procedures are scarce. In this study, we designed and validated a PREM to assess tolerability of endoscopy using conscious sedation. METHODS: The patient-reported scale for tolerability of endoscopic procedures (PRO-STEP) consists of questions within 2 domains and is administered to outpatients at discharge from the endoscopy unit. Domain 1 (intraprocedural) consists of 2 questions regarding discomfort/pain and awareness, whereas domain 2 (postprocedural) consists of 4 questions on pain, nausea, distention, and either throat or anal pain. All questions are scored on a Likert scale from 0 to 10. Cronbach's alpha was used to measure internal consistency of the questions. Multivariable logistic regression was performed to assess predictors of higher scores, reported using adjusted odds ratios and confidence intervals. RESULTS: Two hundred fifty-five patients (91 colonoscopy, 73 gastroscopy, and 91 ERCP) were included. Colonoscopy was the least tolerable procedure by recall, with mean intraprocedural awareness and discomfort scores of 5.1 ± 3.8, and 2.6 ± 2.7, respectively. Consistency between intraprocedural awareness and discomfort/pain yielded an acceptable Cronbach's alpha of .71 (95% confidence interval, .62-.78). Higher use of midazolam during colonoscopy was inversely associated with an intraprocedural awareness score of 7 or higher (per additional mg: adjusted odds ratio, .23; 95% confidence interval, .09-.54). CONCLUSIONS: PRO-STEP is a simple PREM that can be administered after multiple endoscopic procedures using conscious sedation. Future work should focus on its performance characteristics in adverse event prediction.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Forbes N, Chau M, Koury HF, et al. Development and validation of a patient-reported scale for tolerability of endoscopic procedures using conscious sedation. Gastrointest Endosc. 2020. PMID: 33385464. doi:10.1016/j.gie.2020.12.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。